Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Vreuls

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Breast (Edinburgh, Scotland)|October 27, 2023
Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancerLucien E M Duijm, Luc J A Strobbe, Vivian van Breest Smallenburg, et al.
International Journal of Cancer|April 20, 2019
Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional studyJacky D Luiten, Bram Korte, Adri C Voogd, et al.
NPJ Breast Cancer|November 8, 2022
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancerCaner Mercan, Maschenka Balkenhol, Roberto Salgado, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2023
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancerYuwei Wang, Annegien Broeks, Daniele Giardiello, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver StudyXimena Baez-Navarro, Mieke R van Bockstal, Diënna Nawawi, et al.
Breast Cancer Research and Treatment|August 1, 2020
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability studyEmma J Groen, Jan Hudecek, Lennart Mulder, et al.
BMC Medicine|January 8, 2024
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 statusYuwei Wang, Gwen M H E Dackus, Efraim H Rosenberg, et al.
IEEE Transactions on Medical Imaging|February 5, 2019
From Detection of Individual Metastases to Classification of Lymph Node Status at the Patient Level: The CAMELYON17 ChallengePeter Bandi, Oscar Geessink, Quirine Manson, et al.
BMJ Open|November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort studyGwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic TherapyVincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Breast (Edinburgh, Scotland)|October 27, 2023
Trends in the pre-operative diagnosis and surgical management of axillary lymph node metastases in women with screen-detected breast cancerLucien E M Duijm, Luc J A Strobbe, Vivian van Breest Smallenburg, et al.
International Journal of Cancer|April 20, 2019
Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional studyJacky D Luiten, Bram Korte, Adri C Voogd, et al.
NPJ Breast Cancer|November 8, 2022
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancerCaner Mercan, Maschenka Balkenhol, Roberto Salgado, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2023
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancerYuwei Wang, Annegien Broeks, Daniele Giardiello, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver StudyXimena Baez-Navarro, Mieke R van Bockstal, Diënna Nawawi, et al.
Breast Cancer Research and Treatment|August 1, 2020
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability studyEmma J Groen, Jan Hudecek, Lennart Mulder, et al.
BMC Medicine|January 8, 2024
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 statusYuwei Wang, Gwen M H E Dackus, Efraim H Rosenberg, et al.
IEEE Transactions on Medical Imaging|February 5, 2019
From Detection of Individual Metastases to Classification of Lymph Node Status at the Patient Level: The CAMELYON17 ChallengePeter Bandi, Oscar Geessink, Quirine Manson, et al.
BMJ Open|November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort studyGwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic TherapyVincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, et al.
Pageof 4